By: Ethan A. Huff
The vaccine industry is currently hard at work trying to churn out a vaccine for salmonella, a typically food borne pathogen that thrives on factory farms and in other unsanitary settings. CBS 13 News in Sacramento reports that researchers from the University of California, Davis, have been tasked with developing a vaccine that supposedly prevents salmonella, which these researchers say they are on the verge of completing in the very near future.
Rather than attempt to address the root causes of salmonella, which include filthy animal living conditions on industrial farms and the overuse of synthetic antibiotics in conventional livestock, just to name a few, mainstream science is busy concocting new ways to jab people with toxic chemical cocktails that could permanently injure them.
Funded by a grant from the National Institutes of Health, Stephen McSorley and his team of international researchers believe that by closely studying the immune response to infection in mice, they will be able to arrive at a solid vaccine protocol for “curing” salmonella. And their findings thus far, which were recently published in the journal Proceedings of the National Academy of Sciences, seem to indicate that the project is moving forward as planned.
Not surprisingly, Big Pharma is behind this ludicrous endeavor to develop a vaccine for an illness that is largely preventable through improved hygiene, small-scale agriculture, and naturally-boosted human immunity. Drug giant GlaxoSmithKline (GSK) and the Novartis Vaccines Institute for Global Health are both collaborators on the project, which is expected to soon move into human clinical trials.
The development of this new salmonella vaccine appears to also align directly with the vision of a group of researchers in the U.K. who last summer called for the development of 20 new vaccines in the next decade. Their paper, which was published in the journal Lancet, seeks funding for the development of vaccines “beyond classic infections,” including for things like diabetes, degenerative diseases, and even cancer.
So by the looks of it, there could soon be vaccines for virtually everything — a headache, an upset stomach, a paper cut, you name it. Anything mainstream medicine can identify that is a consequence of a underlying condition rather than a cause of it is open game for vaccine development because there is a whole lot of money to be made utilizing this approach to so-called medicine.
To view the original article click here.
To reprint this article, visit the source website for reprinting guidelines